Dr. Thomas Schinecker has been appointed as the President of IFPMA.

Appointment | Dated: 25 Dec 2024

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), based in Geneva, Switzerland, has appointed Dr. Thomas Schinecker, the Chief Executive Officer (CEO) of the Roche Group, as its new President, starting January 1, 2025.

🎯 Key Highlights:

  • - He will take over from the current President, Dr. Albert Bourla, who is also the Chairman and CEO of Pfizer, as he completes his term.
  • - Before this, Dr. Thomas Schinecker served as the Vice-President of IFPMA for two years.

💡 Other Important Facts:

  • (i) Rob Davis, CEO of MSD (also known as Merck & Co., Inc.), has been appointed as the new Vice-President of IFPMA.
  • (ii) In 2024, Pfizer Inc, based in the United States, is the leading pharmaceutical company in the world, followed by Johnson & Johnson and AbbVie.

📚 Test Your Knowledge:

Who has been appointed as the President of IFPMA (International Federation of Pharmaceutical Manufacturers & Associations)?

Correct Answer: Thomas Schinecker

🚀 Quick Recap: